Free Trial

Mike Polark Analyst Performance

Analyst at Robert W. Baird

Mike Polark is a stock analyst at Robert W. Baird focused in the medical sector, covering 7 publicly traded companies. Over the past year, Mike Polark has issued 12 stock ratings, including buy and hold recommendations. While full access to Mike Polark's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mike Polark's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
16 Last 1 Years
Buy Recommendations
62.50% 10 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy62.5%10 ratings
Hold37.5%6 ratings
Sell0.0%0 ratings

Out of 16 total stock ratings issued by Mike Polark at Robert W. Baird, the majority (62.5%) have been Buy recommendations, followed by 37.5% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
71.4% of companies on NASDAQ
5 companies
NYSE
28.6% of companies on NYSE
2 companies

Mike Polark, an analyst at Robert W. Baird, currently covers 7 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
6 companies
85.7%
Manufacturing
1 company
14.3%

Mike Polark of Robert W. Baird specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED PRODUCTS
3 companies
42.9%
MEDICAL INFO SYS
2 companies
28.6%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
1 company
14.3%
MED INSTRUMENTS
1 company
14.3%

Mike Polark's Ratings History at Robert W. Baird

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
5/5/2026Lower Price Target$54.77$50.00Neutral
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2/20/2026Lower Price Target$147.39$200.00Outperform
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2/13/2026Downgrade$59.74Peer Perform
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2/12/2026Set Price Target$68.50$74.00Neutral
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2/12/2026Downgrade$59.74$74.00Neutral
Medline stock logo
MDLN
Medline
1/12/2026Initiated Coverage$40.52$47.00Outperform
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
12/4/2025Boost Price Target$135.46$180.00Outperform
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
11/25/2025Upgrade$117.28$180.00Outperform
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
10/10/2025Boost Price Target$179.55$220.00Outperform
Medtronic PLC stock logo
MDT
Medtronic
6/30/2025Upgrade$86.19Peer Perform
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
5/30/2025Initiated Coverage$15.36$20.00Outperform
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
5/6/2025Boost Price Target$159.67$236.00Outperform
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
5/2/2025Boost Price Target$108.59$150.00Outperform
Insulet Corporation stock logo
PODD
Insulet
4/29/2025Downgrade$259.52Peer Perform
Kestra Medical Technologies, Ltd. stock logo
KMTS
Kestra Medical Technologies
3/31/2025Initiated Coverage$23.43$29.00Outperform
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2/11/2025Lower Price Target$180.96$248.00Outperform